Stock market week-in-review for 5 large GI companies — Nov. 6-10

Here is how five major, publicly traded gastroenterology companies fared in the stock market for the week of Nov. 6 to Nov. 10, 2017.

Advertisement

Note: This data was compiled using Google Finance.

1. Allergan Pharmaceuticals

Opened: $174.91 on Nov. 6
Peaked: $177.38 on Nov. 6
Closed: $172.21 on Nov. 10
Percent change between Nov. 6 and Nov. 10: -1.54 percent

2. Exact Sciences Corp.

Opened: $56.71 on Nov. 6
Peaked: $63.32 on Nov. 8
Closed: $60.37 on Nov. 10
Percent change between Nov. 6 and Nov. 10: 6.45 percent

3. Johnson & Johnson

Opened: $140.08 on Nov. 6
Peaked: $141.84 on Nov. 8
Closed: $139.69 on Nov. 10
Percent change between Nov. 6 and Nov. 10: -0.27 percent

4. Synergy Pharmaceuticals

Opened: $3.02 on Nov. 6
Peaked: $3.18 on Nov. 6
Closed: $2.72 on Nov. 10
Percent change between Nov. 6 and Nov. 10: -9.93 percent

5. Valeant Pharmaceuticals

Opened: $11.49 on Nov. 6
Peaked: $15.72 on Nov. 10
Closed: $15.45 on Nov. 10
Percent change between Nov. 6 and Nov. 10: 34.46 percent

More articles on gastroenterology: 
Last patient completes visit for Immuron’s phase II NASH study — 4 insights
Demonstrating their value — How the Digestive Health Physicians Association is fighting for independent gastroenterology
GI leader to know: Dr. James Singer of Arizona Digestive Health

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.